Oral mizoribine pulse therapy for patients with steroid-resistant and frequently relapsing steroid-dependent nephrotic syndrome

Nephrology Dialysis Transplantation

Volumn 20, Issue 10, 2005, Pages 2243-2247

  Kawasaki, Yukihiko ^a   Hosoya, Mitsuaki ^a   Kobayashi, Schogo ^a   Ohara, Shinichirou ^a   Onishi, Noriko ^a   Takahashi, Ai ^a   Isome, Masato ^a   Suzuki, Hitoshi ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Children; Clinical; Mizoribine oral pulse therapy; Nephrotic syndrome; Steroid resistant nephrotic syndrome

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN A; MIZORIBINE; PREDNISOLONE;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ALOPECIA; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG PULSE THERAPY; DRUG RESPONSE; FEMALE; HUMAN; HUMAN TISSUE; INTERSTITIAL NEPHRITIS; KIDNEY BIOPSY; LEUKOPENIA; LIVER DYSFUNCTION; MALE; NEPHROTIC SYNDROME; PRIORITY JOURNAL; RELAPSE; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; URIC ACID BLOOD LEVEL;

ADMINISTRATION, ORAL; ANTI-INFLAMMATORY AGENTS; CHILD; CHILD, PRESCHOOL; CYCLOSPORINE; DRUG RESISTANCE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; NEPHROTIC SYNDROME; PREDNISOLONE; RECURRENCE; RIBONUCLEOSIDES;

EID: 27144499061     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfh996     Document Type: Article

References (10)

1. Mendoza SA, Tune BM. Management of the difficult nephritic patient. Pediatr Clin North Am 1995; 42: 1459-1468
2. Ingulli E, Singh A, Baqi N, Ahmad H, Moazami S, Tejani A. Aggressive, long-term cyclosporine therapy for steroid-resistant focal segmental glomerulosclerosis. J Am Soc Nephrol 1995; 5: 1820-1825
3. Gregory MJ, Smoyer WE, Sedman A et al. Long-term cyclosporine therapy for pediatric nephrotic syndrome: A clinical and histologic analysis. J Am Soc Nephrol 1996; 7: 543-549
4. Hughes SE, Gruber SA. New immunosuppressive drugs in organ transplantation. J Clin Pharmacol 1996; 36: 1081-1092
5. Yoshioka K, Ohashi Y, Sakai T el al., for the Pediatric Mizoribine Study Group in Japan. A multicenter trial of mizoribine compared with placebo in children with frequently relapsing nephrotic syndrome. Kidney Int 2000; 58; 317-324
6. International Study of Kidney Disease in Children. Early identification of frequent relapsers among children with minimal change nephritic syndrome. J Pediatr 1982; 101: 514-518
7. Tanaka H, Suzuki K, Nakahata T, Sato T, Ito E. Mizoribine oral pulse therapy for a patient with severe lupus nephritis. Pediatr Int 2003; 45: 488-490
8. Kawasaki Y, Suzuki J, Takahashi A, Isome M, Nozawa R, Suzuki H. Mizoribine oral pulse therapy for steroid-dependent nephrotic syndrome. Pediatr Nephrol 2005; 20: 96-98
9. Tanaka H, Suzuki K, Nakahata T, Tsugawa E, Ito E, Waga S. Mizoribine oral pulse therapy for patients with disease flare of lupus nephritis. Clin Nephrol 2003; 60: 390-394
10. Takahashi S, Wakui H, Gustafsson JA, Zilliacus J, Itoh H. Functional interaction of the immunosuppressant mizoribine with the 14-3-3 protein. Biochem Biophys Res Commun 2000; 274: 87-92